Functional polymorphisms in the CD44 gene and acute myeloid leukemia cancer risk in a Chinese population

Molecular Carcinogenesis

Volumn 54, Issue 2, 2015, Pages 102-110

  Wu, Hongchun ^a   Deng, Jieqiong ^a   Zheng, Jian ^a   You, Yonghe ^a   Li, Na ^a   Li, Wei ^a   Wu, Depei ^a   Zhou, Yifeng ^a  

^a THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

Author keywords

Acute myeloid leukemia; CD44; Polymorphisms

Indexed keywords

HERMES ANTIGEN; 3' UNTRANSLATED REGION; CD44 PROTEIN, HUMAN; MICRORNA; MIRN509 MICRORNA, HUMAN;

3' UNTRANSLATED REGION; ACUTE MYELOID LEUKEMIA; ADULT; ALLELE; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CD44 GENE; CHINESE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENETIC TRANSFECTION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PLASMID; SINGLE NUCLEOTIDE POLYMORPHISM; WESTERN BLOTTING; ASIAN CONTINENTAL ANCESTRY GROUP; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETICS; HL 60 CELL LINE; LEUKEMIA, MYELOID, ACUTE; METABOLISM; MIDDLE AGED; TUMOR CELL LINE;

3' UNTRANSLATED REGIONS; ADULT; ANTIGENS, CD44; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CELL LINE, TUMOR; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HL-60 CELLS; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; MICRORNAS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84920628246     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.22078     Document Type: Article

References (43)

1. Nimer SD. Myelodysplastic syndromes. Blood 2008; 111:4841-4851.
2. Valent P, Horny HP, Bennett JM, et al. Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: Consensus statements and report from a working conference. Leuk Res 2007; 31:727-736.
3. Bennett JM, Komrokji RS. The myelodysplastic syndromes: Diagnosis, molecular biology and risk assessment. Hematology 2005; 10:258-269.
4. Jemal A, Thomas A, Murray T, Thun M. Cancer statistics, 2002. CA Cancer J Clin 2002; 52:23-47.
5. Gollin SM. Mechanisms leading to chromosomal instability. Semin Cancer Biol 2005; 15:33-42.
6. Erba HP. Prognostic factors in elderly patients with AML and the implications for treatment. Hematol Am Soc Hematol Educ Program 2007; 2007:420-428.
7. Lang K, Earle CC, Foster T, Dixon D, Van Gool R, Menzin J. Trends in the treatment of acute myeloid leukaemia in the elderly. Drugs Aging 2005; 22:943-955.
8. Owen C, Barnett M, Fitzgibbon J. Familial myelodysplasia and acute myeloid leukaemia-A review. Br J Haematol 2008; 140:123-132.
9. Schlenk RF, Dohner K, Krauter J, et al. Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia. N Engl J Med 2008; 358:1909-1918.
10. Sanz GF, Sanz MA, Vallespi T, et al. Two regression models and a scoring system for predicting survival and planning treatment in myelodysplastic syndromes: A multivariate analysis of prognostic factors in 370 patients. Blood 1989; 74:395-408.
11. Slater ME, Linabery AM, Blair CK, et al. Maternal prenatal cigarette, alcohol and illicit drug use and risk of infant leukaemia: A report from the Children's Oncology Group. Paediatr Perinat Epidemiol 2011; 25:559-565.
12. Le Beau MM, Albain KS, Larson RA, et al. Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: Further evidence for characteristic abnormalities of chromosomes no. 5 and 7. J Clin Oncol 1986; 4:325-345.
13. Thirman MJ, Gill HJ, Burnett RC, et al. Rearrangement of the MLL gene in acute lymphoblastic and acute myeloid leukemias with 11q23 chromosomal translocations. N Engl J Med 1993; 329:909-914.
14. Austin H, Delzell E, Cole P. Benzene and leukemia. A review of the literature and a risk assessment. Am J Epidemiol 1988; 127:419-439.
15. Gunz FW, Veale AM. Leukemia in close relatives-accident or predisposition? J Natl Cancer Inst 1969; 42:517-524.
16. Bizzozero OJ, Jr., Johnson KG, Ciocco A. Radiation-related leukemia in Hiroshima and Nagasaki, 1946-1964.I. Distribution, incidence and appearance time. N Engl J Med 1966; 274:1095-1101.
17. Evans DI, Steward JK. Down's syndrome and leukaemia. Lancet 1972; 2:1322.
18. Horwitz M, Goode EL, Jarvik GP. Anticipation in familial leukemia. Am J Hum Genet 1996; 59:990-998.
19. Crittenden LB. An interpretation of familial aggregation based on multiple genetic and environmental factors. Ann NY Acad Sci 1961; 91:769-780.
20. Horwitz M. The genetics of familial leukemia. Leukemia 1997; 11:1347-1359.
21. Ahmed FE. Gene-gene gene-environment & multiple interactions in colorectal cancer. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 2006; 24:1-101.
22. Konopleva MY, Jordan CT. Leukemia stem cells and microenvironment: Biology and therapeutic targeting. J Clin Oncol 2011; 29:591-599.
23. Ayala F, Dewar R, Kieran M, Kalluri R. Contribution of bone microenvironment to leukemogenesis and leukemia progression. Leukemia 2009; 23:2233-2241.
24. Westhoff MA, Fulda S. Adhesion-mediated apoptosis resistance in cancer. Drug Resist Updat 2009; 12:127-136.
25. Legras S, Gunthert U, Stauder R, et al. A strong expression of CD44-6v correlates with shorter survival of patients with acute myeloid leukemia. Blood 1998; 91:3401-3413.
26. Quere R, Andradottir S, Brun AC, et al. High levels of the adhesion molecule CD44 on leukemic cells generate acute myeloid leukemia relapse after withdrawal of the initial transforming event. Leukemia 2011; 25:515-526.
27. Jiang L, Zhou P, Sun A, et al. Functional variant (-1304T>G) in the MKK4 promoter is associated with decreased risk of acute myeloid leukemia in a southern Chinese population. Cancer Sci 2011; 102:1462-1468.
28. Jiang L, Zhang C, Li Y, et al. A non-synonymous polymorphism Thr115Met in the EpCAM gene is associated with an increased risk of breast cancer in Chinese population. Breast Cancer Res Treat 2011; 126:487-495.
29. Jiang L, Liang J, Jiang M, et al. Functional polymorphisms in the NBS1 gene and acute lymphoblastic leukemia susceptibility in a Chinese population. Eur J Haematol 2011; 86:199-205.
30. Zheng J, Liu B, Zhang L, et al. The protective role of polymorphism MKK 4-1304 T>G in nasopharyngeal carcinoma is modulated by Epstein-Barr virus' infection status. Int J Cancer 2012; 130:1981-1990.
31. Jurinke C, Oeth P, van den Boom D. MALDI-TOF mass spectrometry: A versatile tool for high-performance DNA analysis. Mol Biotechnol 2004; 26:147-164.
32. Zheng J, Jiang L, Zhang L, et al. Functional genetic variations in the IL-23 receptor gene are associated with risk of breast, lung and nasopharyngeal cancer in Chinese populations. Carcinogenesis 2012; 33:2409-2416.
33. Jiang L, Deng J, Zhu X, et al. CD44 rs13347 C>T polymorphism predicts breast cancer risk and prognosis in Chinese populations. Breast Cancer Res 2012; 14:R105.
34. Iida N, Bourguignon LY. New CD44 splice variants associated with human breast cancers. J Cell Physiol 1995; 162:127-133.
35. Ponta H, Sherman L, Herrlich PA. CD44: From adhesion molecules to signalling regulators. Nat Rev Mol Cell Biol 2003; 4:33-45.
36. Loeffler-Ragg J, Germing U, Sperr WR, et al. Serum CD44 levels predict survival in patients with low-risk myelodysplastic syndromes. Crit Rev Oncol Hematol 2011; 78:150-161.
37. Charrad RS, Li Y, Delpech B, et al. Ligation of the CD44 adhesion molecule reverses blockage of differentiation in human acute myeloid leukemia. Nat Med 1999; 5:669-676.
38. Charrad RS, Gadhoum Z, Qi J, et al. Effects of anti-CD44 monoclonal antibodies on differentiation and apoptosis of human myeloid leukemia cell lines. Blood 2002; 99:290-299.
39. Song G, Liao X, Zhou L, Wu L, Feng Y, Han ZC. HI44a, an anti-CD44 monoclonal antibody, induces differentiation and apoptosis of human acute myeloid leukemia cells. Leuk Res 2004; 28:1089-1096.
40. Peterson LF, Wang Y, Lo MC, Yan M, Kanbe E, Zhang DE. The multi-functional cellular adhesion molecule CD44 is regulated by the 8;21 chromosomal translocation. Leukemia 2007; 21:2010-2019.
41. Kansas GS, Dailey MO. Expression of adhesion structures during B cell development in man. J Immunol 1989; 142:3058-3062.
42. Varadarajan R, Licht AS, Hyland AJ, et al. Smoking adversely affects survival in acute myeloid leukemia patients. Int J Cancer 2012; 130:1451-1458.
43. Kim HN, Kim NY, Yu L, et al. Association of GSTT1 polymorphism with acute myeloid leukemia risk is dependent on smoking status. Leuk Lymphoma 2012; 53:681-687.